Medtronic recently reported strong Q2 results, with revenue growth of 5% and an EPS increase. The company is focused on innovation and growth in key areas like TAVR, PFA, and diabetes.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Medtronic recently reported strong Q2 results, with revenue growth of 5% and an EPS increase. The company is focused on innovation and growth in key areas like TAVR, PFA, and diabetes.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing